company background image
OTSU logo

Otsuka Pakistan KASE:OTSU Stock Report

Last Price

PK₨192.32

Market Cap

PK₨2.3b

7D

-3.6%

1Y

32.2%

Updated

21 Dec, 2024

Data

Company Financials

Otsuka Pakistan Limited

KASE:OTSU Stock Report

Market Cap: PK₨2.3b

My Notes

Capture your thoughts, links and company narrative

Otsuka Pakistan Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for Otsuka Pakistan
Historical stock prices
Current Share PricePK₨192.32
52 Week HighPK₨205.03
52 Week LowPK₨105.05
Beta0.27
1 Month Change33.90%
3 Month Change38.22%
1 Year Change32.22%
3 Year Change-21.61%
5 Year Change-44.00%
Change since IPO1,049.17%

Recent News & Updates

Recent updates

Shareholder Returns

OTSUPK PharmaceuticalsPK Market
7D-3.6%-5.4%-4.6%
1Y32.2%160.1%54.3%

Return vs Industry: OTSU underperformed the PK Pharmaceuticals industry which returned 160.1% over the past year.

Return vs Market: OTSU underperformed the PK Market which returned 54.3% over the past year.

Price Volatility

Is OTSU's price volatile compared to industry and market?
OTSU volatility
OTSU Average Weekly Movement10.3%
Pharmaceuticals Industry Average Movement7.1%
Market Average Movement7.1%
10% most volatile stocks in PK Market10.1%
10% least volatile stocks in PK Market4.8%

Stable Share Price: OTSU's share price has been volatile over the past 3 months compared to the PK market.

Volatility Over Time: OTSU's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of PK stocks.

About the Company

FoundedEmployeesCEOWebsite
1988345Moin-ur Rehmanwww.otsuka.pk

Otsuka Pakistan Limited manufactures, markets, and distributes intravenous infusions in Pakistan and Afghanistan. The company offers intravenous solutions, including electrolyte and standard solutions, ampoules, OTSUZOL, and ciprofloxacin and OTSUMOL infusion products; medical devices, such as urea breath test systems, plasline solutions, sirolimus eluting coronary stent system, eucaLIMUS, and eucaVI; clinical nutrition products comprising aminoleban oral, aminovel 600, pan-amin G, aminoleban injection, and proten gold; and therapeutic drugs, which include pletaal and mucosta tablets, as well as oral rehydration therapy supplement for urinary tract. It engages in the trading of pharmaceutical products, nutritional foods, and medical equipment.

Otsuka Pakistan Limited Fundamentals Summary

How do Otsuka Pakistan's earnings and revenue compare to its market cap?
OTSU fundamental statistics
Market capPK₨2.33b
Earnings (TTM)-PK₨160.37m
Revenue (TTM)PK₨3.18b

0.7x

P/S Ratio

-14.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
OTSU income statement (TTM)
RevenuePK₨3.18b
Cost of RevenuePK₨2.68b
Gross ProfitPK₨500.48m
Other ExpensesPK₨660.85m
Earnings-PK₨160.37m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-13.25
Gross Margin15.74%
Net Profit Margin-5.04%
Debt/Equity Ratio192.9%

How did OTSU perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 04:20
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Otsuka Pakistan Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution